Lateral Hypothalamus Expanded plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The lateral hypothalamic area (LHA) is a pivotal region in the hypothalamus that integrates metabolic, arousal, and homeostatic signals. Often called the "feeding center" of the brain, the LHA contains heterogeneous neuronal populations that regulate wakefulness, feeding behavior, motivation, and autonomic functions. Its extensive projections throughout the brain make it a crucial hub connecting internal bodily states with behavior and cognition. [1]
The lateral hypothalamus extends from the medial preoptic area to the mammillary bodies, forming a longitudinal band along the third ventricle. It lies medial to the internal capsule and lateral to the mammillothalamic tract. [2]
The LHA contains several distinct neuronal populations: [3]
Orexin/Hypocretin Neurons [4]
Melanin-Concentrating Hormone (MCH) Neurons [5]
Other Neuronal Types [6]
The orexin system is critical for arousal and wakefulness: [7]
Electrophysiological Properties:
Receptor Distribution:
Functions:
The MCH system has opposing functions:
Functions:
The LHA receives extensive inputs:
The LHA projects widely throughout the brain:
The orexin system is significantly affected in Alzheimer's disease:
Orexin Neuron Loss:
Clinical Implications:
Mechanisms:
LHA involvement in PD includes:
Sleep Disorders:
Non-Motor Symptoms:
Primary orexin deficiency in narcolepsy with cataplexy:
Orexin system measurements:
Orexin Receptor Agonists:
Modulation Strategies:
Non-pharmacological approaches:
The lateral hypothalamus, particularly through its orexin and MCH neuronal populations, serves as a critical integrator of arousal, feeding, and metabolic functions. Orexin neuron degeneration contributes significantly to sleep-wake disturbances in Alzheimer's disease, Parkinson's disease, and narcolepsy. Understanding LHA involvement in neurodegeneration offers potential for biomarkers and therapeutic interventions targeting the orexin system.
Lateral Hypothalamus Expanded plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Lateral Hypothalamus Expanded has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Peyron C, et al. A narcolepsy: loss of hypocretin/orexin neurons. Nat Med. 2000;6(9):991-997. 2000. ↩︎
Frontera JL, et al. Hypothalamic control of wakefulness and sleep. Front Neurol. 2020;11:537970. 2020. ↩︎
Liguori C, et al. Orexinergic system dysfunction in Alzheimer's disease. J Alzheimers Dis. 2020;78(4):1595-1604. 2020. ↩︎
Kohsaka A. Hypothalamic regulation of energy homeostasis. Nihon Rinsho. 2009;67(3):457-464. 2009. ↩︎
Girard D, et al. Orexin, sleep, and Alzheimer disease. Nat Rev Neurol. 2022;18(5):265-266. 2022. ↩︎
Zhang W, et al. Lateral hypothalamic orexinergic projections to the basal forebrain. J Comp Neurol. 2021;529(8):1729-1745. 2021. ↩︎
Burdakov D, et al. Integration of energy homeostasis and arousal. Nat Rev Neurosci. 2021;22(10):577-588. 2021. ↩︎